Thunderbird Partners’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Thunderbird Partners's ELV Position: Q2 2020 in Review
Thunderbird Partners sold out of Elevance Health (ELV) in Q2 2020, closing a stake of 270,095 shares — an estimated $61.3M sold.
Thunderbird Partners first reported a position in ELV in Q4 2019 and held it in 2 quarters. The position peaked at $79.5M in Q4 2019. 1,106 funds tracked by Wall St. Rank hold ELV as of Q2 2020.
- Thunderbird Partners reported no remaining Elevance Health position as of Q2 2020 after selling out during the quarter.
- Thunderbird Partners sold 270,095 Elevance Health shares in Q2 2020, an estimated $61.3M.
- Thunderbird Partners first reported a position in Elevance Health in Q4 2019 and held it in 2 quarters.
- Thunderbird Partners's Elevance Health position peaked at $79.5M in Q4 2019.
- 1,106 funds tracked by Wall St. Rank held Elevance Health as of Q2 2020.
Based on Thunderbird Partners's 13F filing for Q2 2020, filed 14 Aug 2020.